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interfacing,[5–9] conjugated polymers have 
been employed in organic electronic ion 
pumps (OEIP) to deliver not only small 
ions but also large-sized biomolecules 
and drugs under bias voltages.[10–14] For 
example, Simon et al. demonstrated precise 
transport of neurotransmitters to neuron 
cells using OEIPs and monitored the 
response of the cells in vitro.[13] Tybrandt 
et al. designed an OEIP with a 10 µm size 
transfer channel and used it to efficiently 
stimulate single neuron cells by delivering 
a neurotransmitter acetycholine.[14] These 
results indicate that the electroactive 
OEIPs are a promising platform for cell 
stimulation, drug delivery, and microenvi-
ronment regulation in biological systems. 
In comparison with other approaches for 
controllable release triggered by either 
individual external stimuli of light, pH, 
temperature, or combination of multi-
signals,[14–17] voltage-controlled release 
can be more precise and convenient in 
many applications especially for implantable devices. Previ-
ously reported OEIPs are normally based on a lateral structure 
with a small cross-sectional area and a relatively long organic 
transfer channel. Consequently, they require complicated pat-
terning procedure and high operating voltages (tens of volts) 
for pumping ions and demonstrate limited transportation effi-
ciency of ions and biomolecules.[13,14]
Here, we report a novel organic device for molecular release, 
which has a simpler structure and a much lower operating 
voltage than OEIPs. The device has a vertical multilayer struc-
ture and the key is to contain a layer of conjugated polymer 
poly(3-hexyltthiophene) (P3HT) for controlling the molecule 
release. The working mechanism is attributed to the fact that 
the P3HT layer in the device can be tuned between hydro-
phobic and hydrophilic states by a bias voltage due to electro-
chemical oxidation and reduction processes.[18,19] This unique 
property leads to switchable permeability for aqueous solu-
tions across the P3HT layer and thus controllable release of 
molecules from the source layer beneath it. We find that the 
operating voltage of the devices is only ≈1.0 V and the releasing 
rates of several different molecules in the devices are estimated 
to be several ng s−1, which are several orders of magnitude 
higher than that of a typical OEIP. Thanks to the low operating 
voltage, the drug release devices can be handily controlled via 
a mobile phone. As an example, we demonstrate their use in 
Conjugated polymers are attractive in numerous biological applications 
because they are flexible, biocompatible, cost-effective, solution-processable, 
and electronic/ionic conductive. One interesting application is for control-
lable drug release, and this has been realized previously using organic 
electronic ion pumps. However, organic electronic ion pumps show high 
operating voltages and limited transportation efficiency. Here, the first report 
of low-voltage-controlled molecular release with a novel organic device based 
on a conjugated polymer poly(3-hexylthiophene) is presented. The releasing 
rate of molecules can be accurately controlled by the duration of the voltage 
applied on the device. The use of a handy mobile phone to remotely control 
the releasing process and its application in delivering an anticancer drug to 
treat cancer cells are also successfully demonstrated. The working mecha-
nism of the device is attributed to the unique switchable permeability of 
poly(3-hexylthiophene) in aqueous solutions under a bias voltage that can 
tune the wettability of poly(3-hexylthiophene) via oxidation or reduction pro-
cesses. The organic devices are expected to find many promising applications 
for controllable drug delivery in biological systems.
Conjugated Polymers
Conjugated polymers have been extensively investigated for 
biological applications in recent years due to many advantages, 
including solution-based preparation, excellent mechanical 
flexibility, good biocompatibility, low cost, and being ionic and 
electronic conductive.[1–4] Besides their applications as high-
performance organic transistors for biosensing and neural 
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remotely controlled release of an anticancer drug to efficiently 
inhibit cancer cell growth. All of the results provide solid evi-
dences that the organic drug-release devices are promising for 
numerous biological applications in the future.
Figure 1A shows the schematic diagram of the device for 
voltage-controlled molecular release. The device contains a solid 
source electrolyte layer (polyvinylalcohol (PVA)), a P3HT layer, 
and a target electrolyte. In the device fabrication, PVA and P3HT 
thin films were sequentially coated on a patterned ITO electrode 
on a glass substrate and the molecules to be released were incor-
porated in the PVA layer. PVA is an ideal carrier for molecule 
storage because it is soluble in water and can be easily mixed with 
different molecules to act as a molecule reservoir.[20] The release 
of the stored molecules in the source layer can be controlled via 
applying a voltage between the bottom electrode (ITO) beneath 
the PVA layer and the Ag/AgCl electrode in the target electrolyte.
The purpose of coating a P3HT layer on the device is to con-
trol the release of the molecules contained in the PVA layer. It 
has been reported that the wettability of P3HT can be tuned 
by electrochemical oxidation under a bias voltage.[19] To confirm 
this property, we characterized the contact angles of water on 
the P3HT thin film of a device before and after the applica-
tion of a bias voltage of +1.0 V. The bias voltage was applied 
for 3 min on the ITO electrode relative to an Ag/AgCl electrode 
placed in a phosphate buffered saline (PBS) solution. As shown 
in Figure 1B, the contact angle of deionized (DI) water on the 
neutral P3HT film (before voltage application) is 105.3° and it 
is decreased to 59.9° after the oxidation (after voltage applica-
tion). The change of the surface energy of the P3HT thin film 
is related to the charge and density of doped anions, which 
is similar to the case of many other conjugated polymers like 
polypyrrole and polyaniline reported before.[18,19,21–23] When a 
Adv. Mater. 2017, 29, 1701733
Figure 1. Design of a drug release device. A) Schematic diagram (left) and the cross-sectional view (right) of the device based on a P3HT/PVA/ITO 
multilayer and operated in an aqueous solution. The Ag/AgCl electrode was placed in the electrolyte. B) Water contact angles on the P3HT film of a 
device before and after the electrochemical oxidation by a bias voltage applied on the bottom ITO electrode. The recovered contact angle after the 
removal of the bias voltage was fitted with the equation: θ = θ0 + Δθ(1 −e−t/τ).
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positive voltage is applied, small polarons (holes) with positive 
charges are induced in the backbone of polymer chains due 
to the doping of anions from the PBS solution. Consequently, 
dipoles formed by holes and anions can increase the surface 
energy of the P3HT film, leading to the wettability switching 
from hydrophobicity to hydrophilicity.[19] After the removal of 
the bias voltage, the contact angle was then recovered to about 
90° in ≈10 min in the PBS solution, which can be attributed to 
the diffusion of the doped anions back to PBS solution (reduc-
tion process) because no chemical bonds were formed between 
the anions and the P3HT polymer chains. The contact angle θ  
was fitted with the equation: θ = θ0 + Δθ(1 − e−t/τ), where θ0 is the 
initial contact angle for the oxidized P3HT film, Δθ the recovery 
value of the contact angle, t time, and τ is the time constant for 
the recovery process. The best-fitting curve in Figure 1B shows 
that the time constant τ = 4.09 min, which reflects the average 
diffusion time of anions from P3HT back to the PBS solution.
Next, we demonstrate that this hydrophilicity-hydropho-
bicity switching behavior can be readily used for controlling 
the penetration of aqueous solutions across the P3HT film 
and thus the releasing of molecules from the underlying PVA 
layer to the target electrolyte. For this purpose, a device was 
enclosed in a poly(dimethylsiloxane) (PDMS) well where PBS 
solution was filled as an electrolyte. In the device, we added 
fluorescein sodium salt (FSA) C20H10Na2O5 in the PVA layer. 
The molecular weight (Mw) of FSA is 376.28 g mol−1 and the 
structural formula is illustrated in the inset of Figure 2A. The 
concentration of the released FSA in the PBS solution can be 
conveniently determined by measuring its UV–Vis absorption 
spectrum. The experiments were then carried out in the fol-
lowing steps. PBS solution with the volume of 1.5 mL was first 
added to the PDMS well and then an aliquot of PBS solution 
(80 µL) was taken out after every 10 min by a pipette for meas-
urement. Next, a bias voltage of +1.0 V was applied between 
the ITO electrode and the Ag/AgCl electrode in the PBS solu-
tion for 3 min. The same amount of PBS solution (80 µL) was 
taken out and tested each time to check the concentrations 
of the released FSA when the voltage was applied for 1.5 and 
3.0 min. The same analysis was also done at 5, 10, 18, and 
30 min after the removal of the bias voltage.
Each solution sample taken out by a pipette was diluted to 
the volume of 800 µL and characterized under a UV–vis absorp-
tion spectrophotometer. As shown in Figure 2A, negligible light 
absorbance of FSA can be detected in the PBS solution before 
the application of a bias voltage, indicating that FSA in PVA is 
protected very well by the hydrophobic P3HT layer on the top. 
After the application of the bias voltage for 1.5 min, an absorb-
ance peak at ≈490 nm is observed in the solution, suggesting 
that FSA molecules are released across the P3HT film to the 
PBS solution. When the bias voltage is applied for 3 min, the 
absorbance peak intensity is increased by about 106%. Since 
the absorbance peak intensity is proportional to the concentration 
of FSA in PBS, the amount of the released FSA molecules is 
thus doubled when the bias period is extended from 1.5 to 3 min. 
Adv. Mater. 2017, 29, 1701733
Figure 2. Molecular release of organic devices controlled by a bias voltage. UV–vis absorption spectra of A) FSA (C20H10Na2O5, Mw ≈ 376.28 g mol−1) 
and B) Rhodamine 6G (C28H30N2O3•HCl, Mw ≈ 479.02 g mol−1) in PBS solutions at different time. A bias voltage of 1.0 V is applied on the devices for 
3 min. Inset: structural formula of the corresponding molecules. C) The time-dependent concentrations of released molecules for different molecular 
weights before and after the application of bias voltages. The error bars represent the standard errors for at least three identical devices. D) Schematic 
diagram for a neutral P3HT film that is hydrophobic and impermeable to an aqueous solution. E) Small molecules (FSA) can while (F) big molecules 
(Evans Blue) cannot penetrate an oxidized P3HT film.
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After the removal of the bias voltage, the peak intensities 
of the absorbance spectra at 5, 10, 18, and 30 min increase with 
the increase of time, indicating that slow molecular release 
still occurs even without a bias voltage. It is worth noting that 
the releasing rate dramatically decreases with the extension of 
time and the peak intensity tends to saturate after a relatively 
long period (see Figure S1, Supporting Information). The time-
dependent peak intensity of FSA in the PBS solution I(t) after 
the removal of the bias voltage can be fitted with the equation 
I(t) = I0 + ΔI(1 − e−t/δ), where I0 is the initial peak intensity, ΔI 
the increased value to the saturation state, and δ the time con-
stant. The least-square fitting of the data shows that the time 
constant δ is about 28.3 min, which is much longer than the 
recovery time τ for the water contact angle on the P3HT film 
in PBS solution. This result indicates that the releasing rate 
has a nonlinear relationship with the water contact angle on 
the polymer film. To accurately control the releasing amount in 
practical applications, the releasing process should be switched 
off more quickly. Novel conjugated polymers are thus needed, 
which should have a broader tunable range of wettability and 
quicker reduction of the oxidation state after the removal of a 
bias voltage.
It is notable that FSA has negative charge in a PBS solu-
tion.[24,25] So the release of FSA in the device is not directly 
driven by the positive bias voltage applied on the ITO electrode 
because the electrical driving force is opposite to the moving 
direction of the molecules. To further confirm this effect, we 
also applied a negative bias voltage (−0.5 V) on the ITO of a 
device while no molecular release could be observed because 
negative bias cannot lead to the oxidation of the P3HT film (see 
Figure S2, Supporting Information). In comparison, when a 
positive bias (+0.5 V) was applied on the same device, we found 
that molecular release occurred immediately, as evidenced by 
the increased light absorption peak of FSA in the PBS solution. 
These results indicate that the release mechanism is different 
from that of OEIPs reported before.[13]
To better understand the releasing process, molecules with 
different molecular weights were then tested in the devices. 
Four fluorescent organic molecules, including Rhodamine 
6G (C28H30N2O3·HCl, Mw ≈ 479.01 g mol−1), Evans Blue 
(C34H24N6Na4O14S4, Mw ≈ 960.81 g mol−1), fluorescein isothio-
cyanate dextran (FITC3000, Mw ≈ 3000 g mol−1), and fluores-
cein dextran D1821 (FITC10000, Mw ≈ 10 000 g mol−1), were 
introduced in the PVA layer to further investigate the release 
kinetics. These molecules are surrogates for a large class of 
therapeutically useful and bioactive materials such as anticancer 
drugs, peptides, and RNAs. Therefore, the results establish a 
good indication of the device in biological and medical appli-
cations. As shown in Figure 2B, Rhodamine 6G molecules are 
able to diffuse through the P3HT film when a positive voltage 
is applied. Being similar to FSA, the absorbance peak intensity 
of Rhodamine 6G is dramatically increased when a bias voltage 
of 1.0 V is applied for 1.5 min and is further increased with 
the bias duration extended to 3 min. Similarly, the releasing rate 
decreases noticeably after the bias voltage is removed. Opposite 
to FSA, Rhodamine 6G ions are positively charged in the PBS 
solution,[26] which further confirms that the charge of ions is 
not the reason for the release. By calibrating the relationship 
between the absorption peak height and the concentrations of 
fluorescent molecules, we can estimate the time-dependent 
concentrations of both FSA and Rhodamine 6G released from 
the devices, as shown in Figure 2C. The average releasing rates 
for FSA and Rhodamine 6G are estimated to be 7.6 ± 0.8 and 
7.8 ± 0.9 ng s−1, respectively. So the releasing rates for the posi-
tive and negative ions are very similar, indicating that the elec-
trostatic force induced by the bias voltage has little influence on 
the molecular release.
In a stark contrast to FSA and Rhodamine 6G, for the mol-
ecules, including Evans Blue, FITC3000, and FITC10000, with 
greater molecular weights (see Figure S3, Supporting Informa-
tion), the P3HT film is impermeable even when a bias voltage 
is applied for the same period, as shown in Figure 2C. The 
size-selective property of our device can enable a defined trans-
port and supply of particular drug molecules with a specific 
size range in certain applications. Many biological barriers like 
the stratum corneum of skin and cell membrane are essen-
tial to protect organisms from the invasion of environment.[27] 
Although these natural barriers have highly complicated selec-
tivity and mechanisms, one common aspect is that they could 
allow very small molecules to diffuse through while block 
bigger ones.[28] For instance, stratum corneum allows molecules 
with a molecular weight of below 500 g mol−1 to permeate,[29,30] 
which is very similar to our device’s molecular weight cutoff. 
Since the advantage of our technology is the controllable per-
meation, a potential utilization of this technology is to serve as 
an artificial biological barrier after further optimization to sat-
isfy the complex needs of practical applications. For example, 
P3HT films can be deposited on soft substrates to make flexible 
devices for wound healing. Drugs can be controllably released 
to treat wounds. Meanwhile, the devices would allow water and 
air exchange between the wound and the atmosphere and pro-
tect the wound from the penetration of microorganisms, such 
as virus and bacteria, through the device.
After examining the voltage-controlled release of molecules 
in the devices, we next attempt to explain the mechanism. 
P3HT polymers are porous materials containing alternated 
nanosize crystalline domains and amorphous regions.[31] When 
P3HT films are hydrophobic in the neutral state, aqueous 
solutions cannot penetrate across the small pores in the films 
due to the opposite surface tension of liquid, as sketched in 
Figure 2D. However, once P3HT films are oxidized by a bias 
voltage and become hydrophilic, ions or small molecules will 
be able to diffuse through the small pores in the films, which is 
the case shown in Figure 2E. If the molecules or ions are over 
a certain size, the polymer films become impermeable because 
the pores inside them are smaller than the molecular size as 
shown in Figure 2F. This explains why the aforementioned big 
molecules cannot transport across P3HT films.
It is rather difficult to characterize the average size of the 
small pores in a P3HT film. The pore size should be related to 
the morphology of the film that is dependent on the processing 
conditions, the molecular weight, and the regioregularity of the 
material.[31,32] There are some evidences that ions with molec-
ular weight higher than 100 g mol−1 can diffuse into P3HT 
films and induce changes in their conductivity.[33] A similar 
property can be found in poly(3,4-ethylenedioxythiophene):poly
(styrene sulfonate) (PEDOT:PSS) films, in which molecules like 
glutamate, aspartate, and amino butyric acid with molecular 
Adv. Mater. 2017, 29, 1701733
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weights of above 100 g mol−1 can be transferred.[13] But the 
upper limit of the molecular weight for successful molecule 
transfer in conjugated polymers has not been systematically 
characterized yet.
In the above tests, an interesting phenomenon is the slowly 
stopped molecular release after the removal of the applied bias 
voltage, which can be ascribed to the recovery of the P3HT 
films to hydrophilic in water as shown in Figure 1B.[19] So 
the molecular release can be quantitatively controlled by the 
duration of the bias voltage. To further confirm this function, 
devices containing FSA were operated by applying a bias voltage 
of 1.0 V for three steps, and the duration of each step is 1 min, 
followed by a pause period of 5 min without the bias voltage. 
The concentration of the released molecules was character-
ized before and after each step and the results are presented 
in Figure 3A,B. It is notable that significant changes in FSA 
concentration can only be observed after the application of the 
bias voltage at each step, indicating that the releasing process 
can be switched on and off when the bias voltage is set to +1 
and 0 V, respectively, as demonstrated in Figure 3C. Therefore, 
the concentration of the released molecules can be conveniently 
controlled by changing the duration of the bias voltage.
After knowing the effect of voltage application duration, the 
influence of the magnitude of the bias voltage on the releasing 
rate was then characterized. We found that the releasing rate 
increased with the increase of the applied bias voltage (see 
Figure S4, Supporting Information), which can be attributed to 
the improved oxidation level in the P3HT film. As reported in 
our previous work,[19] the P3HT layer can be oxidized to have 
a lower contact angle at a higher bias voltage. Therefore, it is 
reasonable to find that the releasing rate increased with the 
increase of the bias voltage. On the other hand, it is not neces-
sary to apply too high bias voltage because we observed that a 
bias of 2.0 V could damage the P3HT film very quickly. Con-
sidering that the most sensitive tuning voltage is below 1.5 V 
as presented in our previous work,[19] the most suitable bias 
voltage is around 1.0 V. We also prepared devices with the dif-
ferent thicknesses of P3HT layers and found that the releasing 
rate decreased with the increase of P3HT thickness (see 
Figure S5, Supporting Information). This result is reasonable 
because the permeability of FSA molecules should be lower in 
a thicker P3HT film due to a longer diffusion distance.[34]
Since the devices could be conveniently operated by applying 
a low bias, we tried to realize remote control of the molecular 
release by a mobile phone, which will be very useful for many 
applications especially implantable devices in the future. As 
shown in Figure 4A, the device is connected to an Arduino 
UNO chip and the molecular release is switched on and off 
by the mobile phone, corresponding to the bias voltages of +1 
and 0 V applied on the device, respectively. The device was first 
used for the release of FSA. We found that the concentration 
of the released FSA is proportional to the releasing duration 
(see Figure S6, Supporting Information), being consistent with 
the results obtained in previous experiments.
Next, we used devices for the release of a type of biologi-
cally functional molecule cis-diammineplatinum (II) dichlo-
ride H6Cl2N2Pt (cisplatin), which is an anticancer drug with 
a molecular weight (Mw ≈ 300.05 g mol−1) similar to that of 
FSA,[35,36] and show its effect on the cancer cells cultured on 
the device. The release of cisplatin through P3HT film from 
Adv. Mater. 2017, 29, 1701733
Figure 3. Switchable molecular release of organic devices. A) UV–vis absorption spectra of FSA in a PBS solution before and after the application of 
bias voltages. B) The concentration of released FSA (left axis) as a function of time under the application of bias voltage (right axis). The error bars 
were calculated from three devices. C) Schematic diagram for the voltage-controlled permeability and switchable molecule release of a P3HT film.
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the drug carrier PVA to a PBS solution was detected by UV–vis 
absorption measurements at different time and conditions, as 
shown in Figure 4B. It is apparent that the amount of cispl-
atin remained unchanged in the first 10 min in the PVA car-
rier due to the protection of the hydrophobic P3HT film. A pro-
nounced change of the absorption spectra can be observed after 
applying a positive voltage (+1.0 V) on the device for 1.5 min. 
It is obvious that the P3HT film was oxidized and switched to 
be hydrophilic by the bias voltage, thereby leading to rapid dif-
fusion of cisplatin molecules from the drug carrier to the PBS 
solution. When the voltage application period was extended to 
3 min, a further increase in the absorption peak height can be 
observed, indicating that the continuous drug release occurred. 
Then drug release was gradually stopped when the bias voltage 
was switched off and only showed a little increase after 15 min. 
These findings are similar to the cases for FSA and Rhodamine 
6G. To accurately assess the concentration of cisplatin released 
into PBS, a calibration curve for the relationship between the 
UV–vis absorption peak height and the cisplatin concentration 
was obtained as shown in Figure 4B,C. Then the released dos-
ages of cisplatin into PBS solutions were estimated to be 2.13 
and 4.06 µg mL−1 when the bias voltage was applied for 1.5 and 
3 min, respectively. So the average releasing rate of the drug 
is estimated to be ≈34 ng s−1 (or 0.11 nmol s−1), which is three 
orders of magnitude higher than that of acetylcholine release 
from an OEIP device at a bias at 5 V.[14]
Adv. Mater. 2017, 29, 1701733
Figure 4. Remote control of drug release. A) Schematic for the molecular release of an organic device controlled by a mobile phone and bluetooth. 
B) UV–vis absorption spectra of cisplatin released in a PBS solution before and after the application of a bias voltage on a device. C) Light absorption 
spectra of cisplatin solution with different concentrations. D) The calibration curve for the peak intensity versus concentration. The green triangles are 
for the release drug concentrations decided from the peak intensity. E) Viability of cancer cells (MCF-7) in the culture media with released cisplatin as a 
function of bias duration (releasing time) controlled by a mobile phone. The releasing time for IC50 was determined to be 1.4 min from the polynomial 
fitting curve of the viability at different time points.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1701733 (7 of 8)
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A mobile phone was then used to remotely control the 
release of an anticancer drug to treat cancer cells. The solution 
filled in the devices was changed to cell culture medium. Mich-
igan Cancer Foundation-7 (MCF-7) cell lines were cultured on 
the P3HT surface of two devices. One device contained cispl-
atin drug while the other did not possess any drug in the PVA 
layers. Before the application of a bias voltage, cells were able 
to grow well on both devices. Then we applied a voltage of +1 V 
on the ITO electrodes of the devices for 3 min and checked the 
morphology of the MCF-7 cells cultured on the device after-
ward. After 12 h, obvious difference of the morphology of the 
cells between the two samples can be observed (see Figure S7, 
Supporting Information). The MCF-7 cells possess irregular 
shape on the device without drug release, indicating that the 
cells can grow on P3HT film with a good condition. However, 
the cancer cells cultured on the device with released anticancer 
drug from the PVA carrier become round in shape, suggesting 
that the drug release in the device is very effective in influ-
encing the growth of the MCF-7 cancer cells.
To quantitatively illustrate the drug-releasing effect of the 
devices, cell viability under a bias with different duration was 
determined to explore the release condition for the half max-
imal inhibitory concentration (IC50). As a widely used method 
for assessing cell metabolic activity, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay is a colorimetric 
test that is based on NAD(P)H-dependent cellular oxidoreduc-
tase enzymes to reflect the number of viable cells.[37] First, a 
bias of +1.0 V was applied on different devices with cell culture 
medium as an electrolyte for different durations, including 
0, 0.5, 1, 1.5, 2, and 3 min. Then, the devices were kept at room 
temperature for 30 min to fully release the anticancer drug 
and the drug-released culture medium was collected. Next, 
MCF-7 cells at a concentration of 105 cells mL−1 were seeded 
in the culture medium (100 µL) containing the released drug 
in a 96-well plate, with six replicates for each time point. After 
24 h incubation, the cell viability of cells was determined by the 
MTT assay. As shown in Figure 4E, the relative viability of the 
cells is 71.96% for the samples with 0.5 min bias application, 
which means that the concentration of the released cisplatin 
at this condition is not high enough. With the increase of the 
bias duration, the cell viability decreases accordingly due to the 
increased cisplatin concentration. When the bias duration is 
3 min, the cell viability drops to the value of 36.44%, indicating 
an effective cell killing at this condition. By fitting the curve 
with a polynomial function, we can estimate the IC50 value 
of 1.4 min for the devices. In other words, with +1.0 V voltage 
application of 1.4 min, the liberated concentration of cisplatin 
is enough to realize 50% inhibition of the cells.
In summary, we observed that the permeability of P3HT 
films in aqueous solutions can be tuned by a low bias voltage 
for the first time. Based on this interesting effect, we designed 
and prepared novel organic devices for voltage-controlled release 
of different molecules. The device was successfully employed 
to release an anticancer drug cisplatin to inhibit the growth of 
cancer cells by a remote control. The releasing process can be 
conveniently switched on and off via a mobile phone by control-
ling the bias voltage. It is envisaged that the low-cost and dispos-
able organic bioelectronics devices will be extensively used for 
controlled and size-selective drug delivery in biological systems.
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